tiprankstipranks
Advertisement
Advertisement
Moderna falls -8.2%
PremiumThe FlyModerna falls -8.2%
12d ago
Moderna price target raised to $39 from $33 at Morgan Stanley
Premium
The Fly
Moderna price target raised to $39 from $33 at Morgan Stanley
14d ago
Moderna Strengthens Board with New Financial Director
Premium
Company Announcements
Moderna Strengthens Board with New Financial Director
14d ago
Early notable gainers among liquid option names on July 2nd
PremiumThe FlyEarly notable gainers among liquid option names on July 2nd
20d ago
Moderna’s Surprise Surge: Is the mRNA Giant Back?
Premium
Weekend Updates
Moderna’s Surprise Surge: Is the mRNA Giant Back?
25d ago
Moderna rises 14.2%
Premium
The Fly
Moderna rises 14.2%
26d ago
Hold Rating Reiterated on Moderna as Analyst Keeps $49 Price Target Amid Long-Term Pipeline Potential and Near-Term Execution Risks
PremiumRatingsHold Rating Reiterated on Moderna as Analyst Keeps $49 Price Target Amid Long-Term Pipeline Potential and Near-Term Execution Risks
26d ago
Hold Rating Reaffirmed on Moderna as Analyst Highlights High-Risk/High-Reward Pipeline and Keeps Price Target Unchanged at $41
Premium
Ratings
Hold Rating Reaffirmed on Moderna as Analyst Highlights High-Risk/High-Reward Pipeline and Keeps Price Target Unchanged at $41
26d ago
Analyst Maintains Sell on Moderna as Shares Trade Above Unchanged $34 Price Target Despite Scientific Momentum
Premium
Ratings
Analyst Maintains Sell on Moderna as Shares Trade Above Unchanged $34 Price Target Despite Scientific Momentum
26d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100